• FirefoxInstall the new Firefox »
  •  Dow Down 0.45% Nasdaq Down 0.49%

    More On ABBV.PA

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    • Analyst Opinion
    • Analyst Estimates

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    AbbVie Inc. (ABBV.PA)

    -Paris
    54.40 Up 0.40(0.74%) Feb 27, 11:20AM EST
    Add to Portfolio
    Prev Close:54.40
    Open:54.40
    Bid:53.50
    Ask:54.73
    1y Target Est:N/A
    Beta:N/A
    Next Earnings Date:N/A
    Day's Range:54.40 - 54.40
    52wk Range:36.63 - 61.80
    Volume:40
    Avg Vol (3m):21
    Market Cap:86.67B
    P/E (ttm):49.45
    EPS (ttm):1.10
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in EUR.

    Headlines

    • No Headlines available for ABBV.PA at this time.

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):4.34
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est () :N/A
    Quarterly EPS Est () :N/A
    Mean Recommendation*:N/A
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products worldwide. The company’s products include HUMIRA, a biologic therapy administered as a subcutaneous injection to treat autoimmune diseases; VIEKIRA PAK, an all-o... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback